Improving Hepatocellular Carcinoma Surveillance Outcomes in Patients with Cirrhosis after Hepatitis C Cure: A Modelling Study.

Cumming J, Scott N, Howell J, Flores JE, Pavlyshyn D, Hellard ME, Winata LS, Ryan M, Sutherland T, Thompson AJ, Doyle JS, Sacks-Davis R

Hepatitis C

Injecting drug use and hepatitis C virus infection independently increase biomarkers of inflammatory disease risk which are incompletely restored by curative direct-acting antiviral therapy.

Hearps AC, Vootukuru N, Ebrahimnezhaddarzi S, Harney BL, Boo I, Nguyen L, Pavlyshyn D, Dietze PM, Drummer HE, Thompson AJ, Jaworowski A, Hellard ME, Sacks-Davis R, Doyle JS

Hepatitis C Injecting Drug Use